Know Labs, Inc. Form 10-K September 30, 2020
Particle is now a direct, 100% owned subsidiary of the Company
On April 30, 2020, we approved and ratified the incorporation of Particle, Inc., a Nevada corporation. As of September 30, 2020 we are the sole shareholder but have entered into Simple Agreements for Future Equity to sell separate ownership in Particle. Particle is now a direct, 100% owned subsidiary of the Company but our future ownership could be diluted if Particle is successful in raising equity from outside investors. Particle shall utilize the same corporate offices as the Company and shall focus on the development and commercialization of our extensive intellectual property relating to electromagnetic energy
outside of the medical diagnostic arena which remains the parent company’s singular focus with its Bio-RFID technology and its initial application , the noninvasive
measurement of blood glucose.
On June 1, 2020, we approved and ratified entry into an intercompany Patent License Agreement dated May 21, 2020 with our majority owned subsidiary, Particle. Pursuant to the Agreement, Particle shall receive an exclusive non-transferrable license to use certain of our patents and trademarks, in exchange the Company shall receive: (i) a one-time fee of $250,000 upon a successful financing of Particle, and (ii) a quarterly royalty payment equal to the greater of 5% of
the Gross Sales, net of returns, from Particle or $5,000. As of September 30, 2020 Particle has not yet executed a successful financing or generated any sales.
